133 related articles for article (PubMed ID: 22546029)
1. Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age.
Yamaguchi-Okada M; Inoshita N; Nishioka H; Fukuhara N; Yamada S
J Neurosurg Pediatr; 2012 May; 9(5):511-6. PubMed ID: 22546029
[TBL] [Abstract][Full Text] [Related]
2. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
3. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
4. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
5. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
[TBL] [Abstract][Full Text] [Related]
6. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas.
Yamada S; Ohyama K; Taguchi M; Takeshita A; Morita K; Takano K; Sano T
Neurosurgery; 2007 Sep; 61(3):580-4; discussion 584-5. PubMed ID: 17881972
[TBL] [Abstract][Full Text] [Related]
7. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M
J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100
[TBL] [Abstract][Full Text] [Related]
8. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
[TBL] [Abstract][Full Text] [Related]
9. Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age.
Yamada S; Kovacs K; Horvath E; Aiba T
J Neurosurg; 1991 Dec; 75(6):902-5. PubMed ID: 1941118
[TBL] [Abstract][Full Text] [Related]
10. Nonfunctioning pituitary adenomas in pediatric and adolescent patients: a clinical analysis of a series of 14 patients.
Wang H; Wang R; Hu T; Wang Z; Duan Y; Han S; Wu A
J Neurooncol; 2020 May; 148(1):179-186. PubMed ID: 32333187
[TBL] [Abstract][Full Text] [Related]
11. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
12. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
[TBL] [Abstract][Full Text] [Related]
14. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
15. Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma.
Kopp C; Theodorou M; Poullos N; Jacob V; Astner ST; Molls M; Grosu AL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1262-7. PubMed ID: 21530099
[TBL] [Abstract][Full Text] [Related]
16. Contribution of immunohistochemistry, electron microscopy, and cell culture to the characterization of nonfunctioning pituitary adenomas: a study of 40 cases.
Croue A; Beldent V; Rousselet MC; Guy G; Rohmer V; Bigorgne JC; Saint-Andre JP
Hum Pathol; 1992 Dec; 23(12):1332-9. PubMed ID: 1468769
[TBL] [Abstract][Full Text] [Related]
17. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
18. A silent follicle-stimulating hormone-producing pituitary adenoma in a teenage male.
Tamiya H; Fukuhara N; Yoshida N; Suzuki H; Takeshita A; Inoshita N; Nishioka H; Takeuchi Y; Sano T; Yamada S
Endocr Pathol; 2011 Dec; 22(4):212-7. PubMed ID: 21853289
[TBL] [Abstract][Full Text] [Related]
19. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
[TBL] [Abstract][Full Text] [Related]
20. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience.
Erickson D; Scheithauer B; Atkinson J; Horvath E; Kovacs K; Lloyd RV; Young WF
Clin Endocrinol (Oxf); 2009 Jul; 71(1):92-9. PubMed ID: 19170710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
